Acute Respiratory Distress Syndrome Mediates the Association between Early Plasma Soluble Receptor for Advanced Glycation End Products Concentrations and Mortality in Sepsis
Tiffanie K. Jones(University of Pennsylvania), Nuala J. Meyer(Translational Therapeutics (United States)), R.S. Agyekum(Translational Therapeutics (United States)), Todd A. Miano(University of Pennsylvania), Brian J. Anderson(University of Pennsylvania), Rui Feng(University of Pennsylvania), John P. Reilly(University of Pennsylvania), Alexandra P. Turner(University of Pennsylvania), M.G.S. Shashaty(University of Pennsylvania), Thomas Dunn(Translational Therapeutics (United States)), C.A.G. Ittner(University of Pennsylvania)
Cited by 3
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies
|Intensive Care Medicine|2023|855
Comprehensive mapping of immune perturbations associated with severe COVID-19
|Science Immunology|2020|806
Inflammasome-regulated Cytokines Are Critical Mediators of Acute Lung Injury
|American Journal of Respiratory and Critical Care Medicine|2012|566
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
|Nature Medicine|2021|521